Cargando…
10-DEBC Hydrochloride as a Promising New Agent against Infection of Mycobacterium abscessus
Mycobacterium abscessus (M. abscessus) causes chronic pulmonary infections. Its resistance to current antimicrobial drugs makes it the most difficult non-tuberculous mycobacteria (NTM) to treat with a treatment success rate of 45.6%. Therefore, there is a need for new therapeutic agents against M. a...
Autores principales: | Lee, Da-Gyum, Kim, Hye-Jung, Lee, Youngsun, Kim, Jung-Hyun, Hwang, Yoohyun, Ha, Jeongyeop, Ryoo, Sungweon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775589/ https://www.ncbi.nlm.nih.gov/pubmed/35054777 http://dx.doi.org/10.3390/ijms23020591 |
Ejemplares similares
-
Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against Mycobacterium abscessus
por: Lee, Da-Gyum, et al.
Publicado: (2021) -
Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection
por: Kim, Tae Ho, et al.
Publicado: (2019) -
Etamycin as a Novel Mycobacterium abscessus Inhibitor
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020) -
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
por: Bax, Hannelore I, et al.
Publicado: (2019) -
Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)